Exploring Biological Linkage Between Circadian Disruption and Cancer Progression

NCT02011815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2019-09-24

No results posted yet for this study

Summary

The purpose of this study is to explore the possible association between the circadian disruption and cancer progression.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Bong-Jin Hahm, M.D., Ph.D. · Seoul National University Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-10
Primary Completion
2019-02-15
Completion
2019-06-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02011815 on ClinicalTrials.gov